Enzolytics, Inc.: Enzolytics Highlights Its Comprehensive PCT Patent Applications Covering Discovered Conserved Target Epitopes on the SARS-CoV-2 and HIV Viruses

COLLEGE STATION, TX / ACCESSWIRE / March 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/.)In submissions under the Patent Cooperation Treaty (PCT), Enzolytics, Inc. has pending international

Related Keywords

United States ,Texas ,Kostenloser Wertpapierhandel ,Tom Nelson ,Charles Cotropia ,Endotheliotropic Herpesvirus ,Eli Lilly ,While Enzolytics Inc ,Company Contact ,Drug Administration ,Pfizer ,Texasam Institute For Preclinical ,Enzolytics Inc ,Patent Cooperation Treaty ,Artificial Intelligence ,Ebola Virus ,Horse Equine Infectious Virus ,Chicken Anemia Virus ,Cat Feline Leukemia Virus ,Feline Immunodeficiency Virus ,Koala Retrovirus ,Elephant Endotheliotropic Herpesvirus ,Immune Therapeutic ,Inactivated Pepsin Fraction ,Harbor Statement ,Enzolytics ,Highlights ,Comprehensive ,Patent ,Applications ,Covering ,Iscovered ,Conserved ,Target ,Epitopes ,Cars ,Viruses ,